We specifically focused on PEPCK and G-6-Pase, two critical enzymes able to convert non-sugar substances into glucose, since their upregulation is tightly associated to raised gluconeogenesis and explains why these crucial enzymes serve as targets for diabetes treatment [58]. This evidence concerns the gene G6PC1 and diabetes mellitus.